Marco Danova

Medicine · Health Sciences

34h-index4.4kcitations338works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Treatment and Pharmacology(47), Neutropenia and Cancer Infections(36), Cancer Genomics and Diagnostics(35), Acute Myeloid Leukemia Research(23), Colorectal Cancer Treatments and Studies(23)

Publications336 total

The role of co-creation tools in the evaluation and redesign of healthcare services: focus on mystery patient methodology implementation in Italian oncology services
International Journal of Healthcare Management·2024Open Access
The contribution of automated cytometry in immuno-oncology
Methods in cell biology·2023
Supportive therapies in the prevention of chemotherapy-induced febrile neutropenia and appropriate use of granulocyte colony-stimulating factors: a Delphi consensus statement
Supportive Care in Cancer·2022· 2 citedOpen Access
Histochemistry in Advanced Cytometry: From Fluorochromes to Mass Probes
Methods in molecular biology·2022· 2 cited
Cytokinetic-driven myeloprotection after cytotoxic chemotherapy: from an old idea to a new clinical approach
Supportive Care in Cancer·2022
Prognostic role of hematologic parameters of metastatic renal cell carcinoma treated with sunitinib
Tumori Journal·2021· 6 cited
Anti-Cancer Treatment Strategies in the Older Population: Time to Test More?
Geriatrics·2021· 4 citedOpen Access
Baseline Characteristics and Outcomes of Cancer Patients Infected with SARS-CoV-2 in the Lombardy Region, Italy (AIOM-L CORONA): A Multicenter, Observational, Ambispective, Cohort Study
Cancers·2021· 10 citedOpen Access
Granulocyte colony-stimulating factors (G-CSF) and Covid-19: a double-edged sword?
PubMed·2020· 3 cited
Management of chemotherapy-induced neutropenia in patients with cancer: 2019 guidelines of the Italian Medical Oncology Association (AIOM)
Tumori Journal·2020· 16 cited
Management of anemia in patients with cancer: 2019 Italian Association of Medical Oncology (AIOM) guidelines
Tumori Journal·2020· 3 cited
Physician Attitudes and Perceptions of Complementary and Alternative Medicine (CAM): A Multicentre Italian Study
Frontiers in Oncology·2020· 69 citedOpen Access
Recent Advances in the Management of Chemotherapy-Induced Neutropenia: Biosimilar Granulocyte Colony-Stimulating Factor use in Italy
Future Oncology·2020· 1 cited
Immunotherapy in Underrepresented Populations of Patients with Cancer: Do We Have Enough Evidence at Present? A Focus on Patients with Major Viral Infections and Autoimmune Disorders
The Oncologist·2020· 6 citedOpen Access
Budget impact analysis of pegfilgrastim biosimilar in the treatment of febrile neutropenia in Italy
AboutOpen·2020· 2 citedOpen Access
Biosimilar pegfilgrastim and adherence to guidelines for chemotherapy-induced neutropenia and infections in cancer patients.
PubMed·2020· 2 cited
Health technology assessment–based approach to flow cytometric immunophenotyping of acute leukemias: a literature classification
Tumori Journal·2020
Clinical and economic effect of administration of red blood product transfusions in an outpatient supportive care cancer service
Biomedical Reports·2020· 1 citedOpen Access
On-target Toxicities Predictive of Survival in Metastatic Renal Cell Carcinoma (mRCC) Treated With Sunitinib: A Multicenter Retrospective Study
Clinical Genitourinary Cancer·2019· 7 cited
The role of automated cytometry in the new�era of cancer immunotherapy (Review)
Molecular and Clinical Oncology·2018· 16 citedOpen Access
page 1 of 17Next →

Frequent Co-authors

Giuliano Mazzini(18), Alberto Riccardi(17), B. Rovati(10), Monica Giordano(10), Silvia Brugnatelli(9), G. Ucci(7), S. Mariucci(5), George D. Wilson(4), Margherita Girino(4), M. Manzoni(4), Fotios Loupakis(4), Katia Bencardino(4), Carmine Tinelli(4), Gaetano Bergamaschi(4), Mario Cazzola(4), Paolo Gaetani(4), Martina Torchio(4), Edoardo Ascari(3), Paolo Bruzzi(3), Monica Ronzoni(3)